2021 BSE/BCOS威廉亚洲博彩公司：经胸超声心动图评估接受蒽环类药物和/或曲妥珠单抗治疗的成人癌症患者

2021-03-21 英国超声心动图学会 Echo Res Pract.2020 Mar 21;8(1):G1-G18

2021年3月，英国超声心动图学会(BSE)联合英国心血管肿瘤学会(BCOS)共同发布了经胸超声心动图评估接受蒽环类药物和/或曲妥珠单抗治疗的成人癌症患者威廉亚洲博彩公司。肿瘤治疗可导致多种心脏并发症，包括左心室

中文标题：

英文标题：

British Society for Echocardiography and British Cardio-Oncology Society guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab

发布机构：

英国超声心动图学会

发布日期：

2021-03-21

简要介绍：

2021年3月，英国超声心动图学会(BSE)联合英国心血管肿瘤学会(BCOS)共同发布了经胸超声心动图评估接受蒽环类药物和/或曲妥珠单抗治疗的成人癌症患者威廉亚洲博彩公司。肿瘤治疗可导致多种心脏并发症，包括左心室收缩功能障碍、心包疾病以及心脏瓣膜病。超声心动图是诊断和监测这些并发症的重要影像学工具。本文主要针对接受蒽环类药物和／或曲妥珠单抗治疗的成人癌症患者的超声心动图评估提供指导建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=f41871c0020808ea, title=2021 BSE/BCOS威廉亚洲博彩公司：经胸超声心动图评估接受蒽环类药物和/或曲妥珠单抗治疗的成人癌症患者, enTitle=British Society for Echocardiography and British Cardio-Oncology Society guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab, guiderFrom=Echo Res Pract.2020 Mar 21;8(1):G1-G18, authorId=0, author=, summary=2021年3月，英国超声心动图学会(BSE)联合英国心血管肿瘤学会(BCOS)共同发布了经胸超声心动图评估接受蒽环类药物和/或曲妥珠单抗治疗的成人癌症患者威廉亚洲博彩公司。肿瘤治疗可导致多种心脏并发症，包括左心室, cover=https://img.medsci.cn/2021410/1618059542345_2020535.jpg, journalId=0, articlesId=null, associationId=1294, associationName=英国超声心动图学会, associationIntro=, copyright=0, guiderPublishedTime=Sun Mar 21 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年3月，英国超声心动图学会(BSE)联合英国心血管肿瘤学会(BCOS)共同发布了经胸超声心动图评估接受蒽环类药物和/或曲妥珠单抗治疗的成人癌症患者威廉亚洲博彩公司。肿瘤治疗可导致多种心脏并发症，包括左心室收缩功能障碍、心包疾病以及心脏瓣膜病。超声心动图是诊断和监测这些并发症的重要影像学工具。本文主要针对接受蒽环类药物和／或曲妥珠单抗治疗的成人癌症患者的超声心动图评估提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=12127, tagName=经胸超声心动图)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=12127, guiderKeyword=经胸超声心动图, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3936, appHits=119, showAppHits=0, pcHits=507, showPcHits=3817, likes=0, shares=3, comments=9, approvalStatus=1, publishedTime=Sat Apr 10 21:09:10 CST 2021, publishedTimeString=2021-03-21, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Sat Apr 10 20:59:06 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 20:46:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 BSE_BCOS威廉亚洲博彩公司：经胸超声心动图评估接受蒽环类药物和.pdf)])

2021 BSE_BCOS威廉亚洲博彩公司：经胸超声心动图评估接受蒽环类药物和.pdf

下载请点击：

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1222455, encodeId=9f59122245512, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/7c0f75a597954ab7a5bdb0fac75bbde7/d967030764b444c7abadf5049626a073.jpg, createdBy=346f5432424, createdName=于冰馨, createdTime=Wed May 25 21:49:41 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080113, encodeId=c0d91080113e3, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7672298805, createdName=12200d65m15暂无昵称, createdTime=Tue Dec 14 22:44:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080016, encodeId=f9da10800160f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/cf3e63470dcf41a58117b7609eb258af/f137b3eb57b44c109b25f5a631307450.jpg, createdBy=e4c95408509, createdName=中南小哥, createdTime=Tue Dec 14 17:15:21 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971037, encodeId=42ea9e1037cc, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff5b2517502, createdName=124d1424m59暂无昵称, createdTime=Sat Jun 05 08:08:21 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959285, encodeId=6f7195928579, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=ms5000000375290069, createdTime=Thu Apr 22 08:33:08 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
2022-05-25 于冰馨

很好

78 0
[GetPortalCommentsPageByObjectIdResponse(id=1222455, encodeId=9f59122245512, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/7c0f75a597954ab7a5bdb0fac75bbde7/d967030764b444c7abadf5049626a073.jpg, createdBy=346f5432424, createdName=于冰馨, createdTime=Wed May 25 21:49:41 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080113, encodeId=c0d91080113e3, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7672298805, createdName=12200d65m15暂无昵称, createdTime=Tue Dec 14 22:44:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080016, encodeId=f9da10800160f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/cf3e63470dcf41a58117b7609eb258af/f137b3eb57b44c109b25f5a631307450.jpg, createdBy=e4c95408509, createdName=中南小哥, createdTime=Tue Dec 14 17:15:21 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971037, encodeId=42ea9e1037cc, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff5b2517502, createdName=124d1424m59暂无昵称, createdTime=Sat Jun 05 08:08:21 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959285, encodeId=6f7195928579, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=ms5000000375290069, createdTime=Thu Apr 22 08:33:08 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
2021-12-14 12200d65m15暂无昵称

很好

80 0
[GetPortalCommentsPageByObjectIdResponse(id=1222455, encodeId=9f59122245512, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/7c0f75a597954ab7a5bdb0fac75bbde7/d967030764b444c7abadf5049626a073.jpg, createdBy=346f5432424, createdName=于冰馨, createdTime=Wed May 25 21:49:41 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080113, encodeId=c0d91080113e3, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7672298805, createdName=12200d65m15暂无昵称, createdTime=Tue Dec 14 22:44:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080016, encodeId=f9da10800160f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/cf3e63470dcf41a58117b7609eb258af/f137b3eb57b44c109b25f5a631307450.jpg, createdBy=e4c95408509, createdName=中南小哥, createdTime=Tue Dec 14 17:15:21 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971037, encodeId=42ea9e1037cc, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff5b2517502, createdName=124d1424m59暂无昵称, createdTime=Sat Jun 05 08:08:21 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959285, encodeId=6f7195928579, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=ms5000000375290069, createdTime=Thu Apr 22 08:33:08 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
2021-12-14 中南小哥

很好

91 0
[GetPortalCommentsPageByObjectIdResponse(id=1222455, encodeId=9f59122245512, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/7c0f75a597954ab7a5bdb0fac75bbde7/d967030764b444c7abadf5049626a073.jpg, createdBy=346f5432424, createdName=于冰馨, createdTime=Wed May 25 21:49:41 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080113, encodeId=c0d91080113e3, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7672298805, createdName=12200d65m15暂无昵称, createdTime=Tue Dec 14 22:44:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080016, encodeId=f9da10800160f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/cf3e63470dcf41a58117b7609eb258af/f137b3eb57b44c109b25f5a631307450.jpg, createdBy=e4c95408509, createdName=中南小哥, createdTime=Tue Dec 14 17:15:21 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971037, encodeId=42ea9e1037cc, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff5b2517502, createdName=124d1424m59暂无昵称, createdTime=Sat Jun 05 08:08:21 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959285, encodeId=6f7195928579, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=ms5000000375290069, createdTime=Thu Apr 22 08:33:08 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
2021-06-05 124d1424m59暂无昵称

666

87 0
[GetPortalCommentsPageByObjectIdResponse(id=1222455, encodeId=9f59122245512, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210224/7c0f75a597954ab7a5bdb0fac75bbde7/d967030764b444c7abadf5049626a073.jpg, createdBy=346f5432424, createdName=于冰馨, createdTime=Wed May 25 21:49:41 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080113, encodeId=c0d91080113e3, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7672298805, createdName=12200d65m15暂无昵称, createdTime=Tue Dec 14 22:44:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080016, encodeId=f9da10800160f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/cf3e63470dcf41a58117b7609eb258af/f137b3eb57b44c109b25f5a631307450.jpg, createdBy=e4c95408509, createdName=中南小哥, createdTime=Tue Dec 14 17:15:21 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971037, encodeId=42ea9e1037cc, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff5b2517502, createdName=124d1424m59暂无昵称, createdTime=Sat Jun 05 08:08:21 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959285, encodeId=6f7195928579, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210425/188bc6472a1742d09222864964fb4cca/508399781e704ed38acfdf86b724aef5.jpg, createdBy=d0e75483900, createdName=ms5000000375290069, createdTime=Thu Apr 22 08:33:08 CST 2021, time=2021-04-22, status=1, ipAttribution=)]
2021-04-22 ms5000000375290069

学习

82 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管威廉亚洲博彩公司

2021 BSE/BCOS威廉亚洲博彩公司：经胸超声心动图评估接受蒽环类药物和/或曲妥珠单抗治疗的成人癌症患者

相关威廉亚洲博彩公司

拓展阅读

科室

工具

服务

心血管威廉亚洲博彩公司

2021 BSE/BCOS威廉亚洲博彩公司 ：经胸超声心动图评估接受蒽环类药物和/或曲妥珠单抗治疗的成人癌症患者

相关威廉亚洲博彩公司

拓展阅读

科室

工具

服务

2021 BSE/BCOS威廉亚洲博彩公司：经胸超声心动图评估接受蒽环类药物和/或曲妥珠单抗治疗的成人癌症患者